Analyst Alerts: MedAssets, Neurocrine, Chefs Warehouse, Gilead Sciences, HMA Mar 19th

MedAssets, Inc. (NASDAQ:MDAS): Piper Jaffray says MedAssets’ group purchasing organization customer Ascension Health announced Friday that it was forming its own group purchasing organization, or GPO. Piper adds that while Ascension said it intends to maintain a relationship with MedAssets, the official Health and Human Services approval suggests Ascension will direct purchasing volumes to the independent GPOs if the price offered is better than its own GPO. Piper believes Ascension’s GPO could further erode MedAssets’ market share and maintains an Underweight rating on the stock.

Neurocrine Biosciences Inc. (NASDAQ:NBIX): Piper Jaffray named Neurocrine Biosciences its bold call of the month ahead of next week’s Phase IIa data for NBI-98854, a VMAT2 inhibitor for the treatment of tardive dyskinesia. The firm believes shares are pricing in little to no value for NBI-98854 and views the data release as a low risk, high reward event. Piper reiterates an Overweight rating on Neurocrine Biosciences with a $14 price target.

The Chefs Warehouse, Inc (NASDAQ:CHEF): After meeting with Chef’s Warehouse’s management, BMO Capital believes the company will have continued revenue growth momentum in FY12 and beyond. The firm thinks that the company has a significant competitive advantage over its peers, and BMO maintains an Outperform rating on the shares.

Gilead Sciences Inc. (NASDAQ:GILD): After meeting with a HIV expert, Wells Fargo expects Gilead’s quad treatment for HIV to enable the company to meaningfully increase its margins and raise its market share. The firm thinks the stock remains undervalued for the long-term ,and it maintains an Outperform rating.

Health Management Associates Inc. (NYSE:HMA): Credit Suisse recommends buying Health Management on recent underperformance . The firm is not concerned with recent headlines and believes organic growth estimates will prove conservative. Shares are Outperform rated with a $12 price target.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.

To contact the reporter on this story: Derek Hoffman at

To contact the editor responsible for this story: Damien Hoffman at